Breakthrough fungemia caused by Rhodotorula mucilaginosa during anidulafungin therapy

J Microbiol Immunol Infect. 2019 Aug;52(4):674-675. doi: 10.1016/j.jmii.2018.01.001. Epub 2018 Feb 1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged, 80 and over
  • Anidulafungin / standards
  • Anidulafungin / therapeutic use*
  • Antifungal Agents / standards
  • Antifungal Agents / therapeutic use*
  • Drug Resistance, Fungal
  • Fatal Outcome
  • Fungemia / drug therapy*
  • Fungemia / microbiology*
  • Humans
  • Male
  • Rhodotorula / isolation & purification*

Substances

  • Antifungal Agents
  • Anidulafungin